Abstract:Objective To investigate the effects of different metastatic sites on the prognosis of extensive?stage small cell lung cancer ( SCLC ) . Methods A retrospective analysis was performed among 322 patients pathologically or cytologically diagnosed with extensive?stage SCLC ( stage ⅠV defined by the seventh edition of the American Joint Committee on Cancer) who were admitted to our hospital from 2011 to 2015. In those patients, 246 had primary lesions with distant metastasis and 76 primary lesions with non?regional lymph node metastasis;261 had single?organ metastasis and 61 multi?organ metastases. Survival rates were calculated using the Kaplan?Meier method. Between?group comparison of the survival was made by the log?rank test. A multivariate prognostic analysis was made by the Cox proportional hazard model. Results In all the patients, the median survival time ( MST) was 11. 7 months;1?and 2?year overall survival ( OS) rates were 47. 9% and 19. 5%, respectively. The patients with single?organ metastasis had significantly longer MST and significantly higher 1?and 2?year OS rates than the patients with multi?organ metastases ( 12. 4 vs. 8. 9 months;52. 5% vs. 30. 5%;21. 9% vs. 11. 2%;P=0. 014) . In the patients with single?organ metastasis, those with liver metastasis had the worst prognosis with a MST of 8. 5 months, while those with non?regional lymph node metastasis had the best prognosis with a MST of 14. 5 months ( P= 0. 001 );there was no significant difference in the prognosis between patients with metastasis to different organs other than the liver ( P=0. 139) . In the patients with multi?organ metastases, those with liver metastasis and bone metastasis had the worst prognosis ( P=0. 016,0. 006);there was no significant relationship between brain metastasis and the prognosis of extensive?stage SCLC with multi?organ metastases ( P=0. 995) . There was no significantdifference in the prognosis between those with liver metastasis only and multi?organ metastases ( P=0. 862) . Conclusions Liver metastasis predicts the worst prognosis in patients initially diagnosed with extensive?stage SCLC and single?organ metastasis. Liver metastasis and bone metastasis predict the worst prognosis in patients with multi?organ metastases. Brain metastasis has no significant effect on the prognosis. There is no significant difference in the prognosis of extensive?stage SCLC between patients with single?and multi?organ metastases once liver metastasis occurs.

Impact of sites versus number of metastases on survival of patients with organ metastasis from newly diagnosed cervical cancer.

Impact of the Number of Metastastatic Organ on Prognosis in Non-small Cell Lung Cancer

Sites of Distant Metastases and Overall Survival in Ovarian Cancer: A Study of 1481 Patients

Metastasis patterns and survival analysis of 572 patients with metastatic cervical cancer:a hospital-based real world study

Site-specific Distant Metastases and Overall Survival in Sarcomatoid Renal Cell Carcinoma: A Study of 378 Patients

Clinical Correlates and Prognostic Value of Different Metastatic Sites in Gastric and Colorectal Signet Ring Cell Carcinoma

Pattern of Distant Extrahepatic Metastases in Primary Liver Cancer: a SEER Based Study.

Extrahepatic metastasis markedly impact on the survival in hepatocellular carcinoma patients

Heterogeneity and prognosis of single organ metastases in gastric cancer

The Effects of a Prior Malignancy on the Survival of Patients with Ovarian Cancer: a Population-Based Study

The Incidence and Effect of Different Organ Metastasis on the Prognosis of NSCLC.

The Prognostic Value of Multiorgan Metastases in Patients with Non-Small Cell Lung Cancer and Its Variants: a SEER-based Study

Clinical Associations and Prognostic Value of Site-Specific Metastases in Non-Small Cell Lung Cancer: A Population-Based Study

Prognostic Factors For Patients With Postoperative Metastasis From Non-Small-Cell Lung Cancer

The Clinicopathological Features and Survival Outcomes of Patients with Different Metastatic Sites in Stage IV Breast Cancer

Effect of tumor number on the survival of patients of colorectal cancer liver metastases undergoing hepatic resection

Metastatic Characteristics and Prognosis of Non-Small Cell Lung Cancer

Incidence, clinical risk and prognostic factors for liver metastasis in patients with cervical cancer: a population-based retrospective study

Prognostic Effect of Liver Metastasis in Lung Cancer Patients with Distant Metastasis.

The survival analysis of different metastasis sites for 332 patients of extensive stage small cell lung cancer

MA22.07 Prognostic Value of Distant Organ-Specific Metastases in Newly Diagnosed Lung Neuroendocrine Tumors: A Population-Based Study